The US National Academy of Inventors (NAI) has set an exemplary standard for honoring academic innovation and ingenuity. On December…

In the realm of modern physics, the investigation of photoelectron spectra has unveiled a plethora of insights concerning the intricate…

Proteins are the molecular workhorses of cells, each performing specialized tasks essential to cellular health and function. Understanding how these…

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please…

Light Horse Therapeutics is off to the races, rounding up a $62 million series A and tacking on a Novartis…

Armed with $115 million and a clinical-stage asset, another player is emerging in the increasingly crowded T cell engager (TCE)…

Young biotech Dropshot Therapeutics has hooked in Etherna Immunotherapies with an RNA pact that could net up to $950 million.…

In a groundbreaking advancement for renewable energy technology, researchers at Åbo Akademi University in Finland have made significant strides in…

After Vanda Pharmaceuticals’ phase 3 miss and FDA rejection for its stomach disorder candidate, CEO Mihael Polymeropoulos, M.D., is calling…

It’s been a rough month for several clinical amyotrophic lateral sclerosis (ALS) candidates, but that’s not stopping Eli Lilly from…